17-76737321-G-C

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001195427.2(SRSF2):​c.-161C>G variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000451 in 975,418 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.00020 ( 0 hom., cov: 35)
Exomes 𝑓: 0.000017 ( 0 hom. )

Consequence

SRSF2
NM_001195427.2 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.26

Publications

32 publications found
Variant links:
Genes affected
SRSF2 (HGNC:10783): (serine and arginine rich splicing factor 2) The protein encoded by this gene is a member of the serine/arginine (SR)-rich family of pre-mRNA splicing factors, which constitute part of the spliceosome. Each of these factors contains an RNA recognition motif (RRM) for binding RNA and an RS domain for binding other proteins. The RS domain is rich in serine and arginine residues and facilitates interaction between different SR splicing factors. In addition to being critical for mRNA splicing, the SR proteins have also been shown to be involved in mRNA export from the nucleus and in translation. Two transcript variants encoding the same protein and one non-coding transcript variant have been found for this gene. In addition, a pseudogene of this gene has been found on chromosome 11. [provided by RefSeq, Sep 2010]
MFSD11 (HGNC:25458): (major facilitator superfamily domain containing 11) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BS2
High AC in GnomAd4 at 30 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SRSF2NM_001195427.2 linkc.-161C>G 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 3 ENST00000359995.10 NP_001182356.1 Q01130-1A0A024R8U5Q53FN0
SRSF2NM_001195427.2 linkc.-161C>G 5_prime_UTR_variant Exon 1 of 3 ENST00000359995.10 NP_001182356.1 Q01130-1A0A024R8U5Q53FN0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SRSF2ENST00000359995.10 linkc.-161C>G 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 3 1 NM_001195427.2 ENSP00000353089.5 Q01130-1
SRSF2ENST00000359995.10 linkc.-161C>G 5_prime_UTR_variant Exon 1 of 3 1 NM_001195427.2 ENSP00000353089.5 Q01130-1
ENSG00000267168ENST00000587459.1 linkc.239-961G>C intron_variant Intron 1 of 1 5 ENSP00000466829.1 K7EN84

Frequencies

GnomAD3 genomes
AF:
0.000197
AC:
30
AN:
152096
Hom.:
0
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.000700
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000170
AC:
14
AN:
823204
Hom.:
0
Cov.:
10
AF XY:
0.00000734
AC XY:
3
AN XY:
408738
show subpopulations
African (AFR)
AF:
0.000623
AC:
12
AN:
19276
American (AMR)
AF:
0.00
AC:
0
AN:
18122
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
15268
East Asian (EAS)
AF:
0.00
AC:
0
AN:
31470
South Asian (SAS)
AF:
0.00
AC:
0
AN:
46690
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
29304
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2644
European-Non Finnish (NFE)
AF:
0.00000321
AC:
2
AN:
623014
Other (OTH)
AF:
0.00
AC:
0
AN:
37416
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.543
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000197
AC:
30
AN:
152214
Hom.:
0
Cov.:
35
AF XY:
0.000202
AC XY:
15
AN XY:
74388
show subpopulations
African (AFR)
AF:
0.000698
AC:
29
AN:
41560
American (AMR)
AF:
0.0000653
AC:
1
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5150
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10588
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67992
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.537
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
41904

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
0.61
DANN
Benign
0.72
PhyloP100
-1.3
PromoterAI
0.25
Neutral
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.1

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3744061; hg19: chr17-74733403; API